Late-breaking Trials from the 2016 American Heart Association's Scientific Sessions

详细信息    查看全文

• 作者：Kyle D. Buchanan ; ^{Kyle.D.Buchanan@medstar.net} ; M. Chadi Alraies ; Alexandre H. Kajita ; Toby Rogers ; Edward Koifman ; Arie Steinvil
• 关键词：Transcatheter aortic valve replacement ; Coronary artery disease ; Heart failure ; Atrial fibrillation
• 刊名：Cardiovascular Revascularization Medicine
• 出版年：2017
• 出版时间：January-February 2017
• 年：2017
• 卷：18
• 期：1
• 页码：70-74
• 全文大小：244 K
• 卷排序：18

文摘

The late breaking trials released at the American Heart Association scientific sessions conference in November in New Orleans, LA covered a wide range of topics, including new devices within the field of heart failure, new registry data on transcatheter aortic valve replacement (TAVR) in intermediate risk patients, and medical management of peripheral arterial disease, coronary artery disease, and hypercholesterolemia. The following review highlights the late breaking trials presented at the conference that will have significant impact on clinical practice.